BioCardia, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BCDA Nasdaq 2830 www.biocardia.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioCardia, Inc.

BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting - Oct 7th, 2026 7:00 am
BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter - Oct 1st, 2026 7:15 am
BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission - Sep 23rd, 2026 7:15 am
BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference - Sep 10th, 2026 6:30 am
BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval - Aug 24th, 2026 6:30 am
BioCardia (BCDA) Q2 2026 Earnings Call Transcript - Aug 19th, 2026 4:28 pm
BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulatory Wins in Japan and US ... - Aug 12th, 2026 11:04 pm
BioCardia, Inc. Q2 2026 Earnings Call Summary - Aug 12th, 2026 7:00 pm
BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results - Aug 12th, 2026 2:05 pm
BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026 - Aug 5th, 2026 1:16 pm